Introduction
and characteristic ultrastructural changes including endothelial cytoplasmic projections and granular matIgA nephropathy associated with liver disease (hepatic erial in a widened subendothelial space with clusters IgAN ) is the commonest form of secondary IgAN. It of vesicles in the mesangium and glomerular capillary is particularly common in alcoholic liver disease, which wall [4] . The available information comes from autitself is associated with disorders of the IgA immune opsy studies or from studies which have used a wide system [1, 2] but also occurs in other forms of cirrhosis range of criteria for biopsy. No systematic prospective and chronic hepatitis. It is characterized by microscopic study in a large population of cirrhotics has been haematuria, proteinuria, elevated serum IgA levels and undertaken that would provide robust incidence data, mesangial deposits of IgA. Although usually a clinically nor have large cohorts been studied to define the silent condition, a small percentage of patients present association of hepatic IgAN with other chronic liver with nephrotic syndrome and renal impairment that disease, such as non-alcoholic cirrhosis or chronic can rarely progress to end-stage renal failure.
hepatitis. It has been suggested that these observations are simply the coincidence of two common conditions, alcoholic cirrhosis and primary . Although the major-mesangial interposition and splitting of the GBM are ity of these reports are in patients with alcoholic liver more commonly seen than in primary IgAN. disease, glomerular disease with mesangial IgA is also described in patients with other chronic liver disease
Clinical features of hepatic IgAN
and therefore, although this is sometimes described as cirrhotic GN, the term hepatic IgAN is preferred. The three most commonly found patterns of glomerular Autopsy studies indicate that hepatic IgAN, like primary IgAN, may be clinically silent and is usually an disease in cirrhotics are hepatic IgAN, HCV-associated GN, and hepatic glomerulosclerosis, i.e. an MCGN-asymptomatic condition: the majority presenting with microscopic haematuria, proteinuria, and in some cases mild renal impairment [6 ] . As in primary IgAN microCorrespondence and offprint requests to: Dr Shideh Pouria, Renal scopic haematuria is the dominant urine abnormality. syndrome (although this may not be easy to assess in deposition provoked by liver injury, such as administration of carbon tetrachloride or alcohol, and bile the presence of hypoalbuminaemia due to liver disease) and renal failure. One consecutive study in cirrhotics duct ligation. Consequently in hepatic IgAN, just as in primary IgAN, lessons about the prime mechanism indicated that 9.6% of cirrhotics have a nephritic urine and 1.6% are nephrotic [7] .
of mesangial IgA deposition cannot easily be learnt from animal models and must largely be inferred from The activity of the urinary sediment correlates with the severity of the glomerular lesions and degree of human studies. mesangial cell proliferation [8] . The disease is often static and only rarely does it progress to end-stage renal failure. No correlation has been found between IgA system abnormalities in hepatic IgAN the severity of liver failure and the extent of the glomerular disease. There is no established treatment Serology for hepatic IgAN and the prognosis depends on the progression of the hepatic disease. There is no consist-Raised serum IgA levels (up to 2-4 times normal ) are ent evidence that improvement in the hepatic disease strongly correlated with both alcoholic liver disease improves the renal disease, although a case has been and the presence of IgA mesangial deposits [8, 10, 11] . reported in which surgical correction of portal hyper-Increased circulating IgA antibodies against common tension in a child was associated with remission of food and microbial antigens are reported in chronic nephrotic syndrome due to hepatic IgAN [9] . Limited liver disease. Circulating IgA immune complexes re-biopsy data suggest that the glomerular disease (IgAIC ) are elevated in up to 80% of patients with usually remain morphologically stable over a number alcoholic cirrhosis, and are higher in the presence of of years.
glomerulonephritis [12, 13] . A major proportion of these complexes may be cryoglobulins (present in up to 40% of cirrhotics). There is no correlation between
The human IgA system the IgAIC levels and degree of liver damage. Both IgA1 and IgA2 levels are found to be elevated and the
IgA synthesis
IgA2 levels are proportionally higher in most studies In man 90% of serum IgA is monomeric IgA1 and [14] . The ratio of IgA1:IgA2 is not linked to degree marrow derived. The majority of IgA synthesis in the of liver damage [15] . Whereas in health 90% of circulatbody, however, is mucosal, predominantly polymeric ing IgA is monomeric, pIgA represents 25-45% of IgA (pIgA) with IgA1 and IgA2 in about equal serum IgA in alcoholic cirrhosis [11] . Serum sIgA also proportions. This pIgA reaches mucosal fluids by starts to increase as liver damage becomes apparent translocation through the epithelium via the polymeric [14] possibly through interruption of normal transepiimmunoglobulin receptor, during which process the thelial mucosal transport of pIgA due to the adverse pIgA gains secretory component (SC ) and becomes effects of alcohol or other toxins. C3 complement levels secretory IgA (sIgA). In health there is little or no are often depressed but it is not clear to what extent communication between the mucosal and systemic this represents consumption by IC or cryoglobulins, immune systems, and little mucosal pIgA and virtually or reflects failing liver synthesis. no sIgA reach the circulation. 
Tissue IgA deposition

Animal models of hepatic IgAN
also SC binding of mesangial IgA1, indicating the presence of pIgA [12] , although SC itself is not present so that sIgA is not being deposited in the mesangium. There are significant differences between the IgA immune system in man compared to laboratory Hepatic IgA deposits are a particular feature of alcoholic liver disease seen in 78% of alcoholics as animals. This includes differences in the structure of IgA subclasses, particularly IgA1 and in hepatic clear-opposed to only 12% of non-alcoholic liver disease, IgA1 being found in a continuous pattern along the ance of IgA. This restricts the direct application to human disease of rodent models of mesangial IgA hepatic sinusoids [15] . IgAN is a relatively common complication of chronic an auto-amplification loop in vivo [19] . It is difficult liver disease, particularly alcoholic cirrhosis, although to define a marrow or mucosal system abnormality on only in a minority will it have a substantial clinical the basis of such data since the destination of the impact. There is no specific treatment for those who circulating trafficking B cells used in these studies develop nephrotic syndrome and renal impairment. cannot be determined.
Apart from meeting the therapeutic needs of this small group of patients, further studies of the pathogenesis Production of abnormal IgA of hepatic IgAN may provide valuable new insights into IgA pathobiology, and may also expand our In primary IgAN, circulating IgA1 has been shown to have abnormal O-glycosylation at the hinge region, understanding of the range of mechanisms of tissue IgA deposition, which may provide new insights into which may modify its molecular interactions, influencing mesangial deposition and subsequent glomerular primary IgAN. injury through interactions with matrix proteins, IgA receptors on mesangial cells and white cells, and com-
